The Study on Therapeutic Effects of Lactulose and L-ornithine-L-aspartate on Patients with Hepatic Encephalopathy
Wanning Chen
Abstract
Wanning Chen
Abstract
Objective To observe the therapeutic effects of Lactulose and L-ornithine-L-aspartate on hepatic encephalopathy. Methods Sixty patients with hepatic encephalopathy were randomly divided into therapy group (n= 30) and control group (n=30). Patients in the control group were treated with routine comprehensive therapy while those in the therapy group received combined lactulose and L-ornithine-L-aspartate .The blood ammonia, AST and TBiL were examined and the efficacy was compared between the two groups before and after the treatment. Results Combined lactulose with L-ornithine-L-aspartate significantly decreased blood ammonia and improved hepatic function in therapy group(P 0.05);Hepatic encephalopathy score was lower than the control group(P0.05); The efficiency of therapy group was 86.7% and control group was 60% respectively(P0.05). Conclusion Combined lactulose with L-ornithine-L-aspartate can significantly increase the treatment to hepatic encephalopathy and has no adverse reaction. Therefore, this therapeutic protocol is one of effective method now.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the therapeutic effects of Lactulose and L-ornithine-L-aspartate on hepatic encephalopathy. Methods Sixty patients with hepatic encephalopathy were randomly divided into therapy group (n= 30) and control group (n=30). Patients in the control group were treated with routine comprehensive therapy while those in the therapy group received combined lactulose and L-ornithine-L-aspartate .The blood ammonia, AST and TBiL were examined and the efficacy was compared between the two groups before and after the treatment. Results Combined lactulose with L-ornithine-L-aspartate significantly decreased blood ammonia and improved hepatic function in therapy group(P 0.05);Hepatic encephalopathy score was lower than the control group(P0.05); The efficiency of therapy group was 86.7% and control group was 60% respectively(P0.05). Conclusion Combined lactulose with L-ornithine-L-aspartate can significantly increase the treatment to hepatic encephalopathy and has no adverse reaction. Therefore, this therapeutic protocol is one of effective method now.
Key concepts: Lactulose, Hepatic encephalopathy, Medicine, Gastroenterology, Internal medicine, Adverse effect, Encephalopathy, Therapeutic effect